UnitedHealth Group’s acquisition of home health company LHC Group is tentatively scheduled to close on Thursday, February 23, pending regulatory approvals, according to a Nasdaq notice. In anticipation of the closing, UHC stock will be halted immediately following an after-hours session at 8 p.m. Feb. 22, Healthcare Finance reports.
The Nasdaq delisting comes after recent reports that the Federal Trade Commission was unlikely to challenge the combination.
The $5.4 billion deal, announced in March 2022, follows a filing with the SEC that stated the combination would close during the first quarter of this year.
The deal was extended until March 28 after the FTC in June issued a second request for information. Read more.
